Diabetes Mellitus — Community- and mHealth-Based Integrated Management of Diabetes in Primary Healthcare in Rwanda
Citation(s)
Agarwal S, Rosenblum L, Goldschmidt T, Carras M, Goal N, Labrique AB Mobile Technology in Support of Frontline Health Workers. John Hopkins Univ Glob mHealth Initiat 2016 [Internet]. 2016;86. Available from: https://dl.dropboxusercontent.com/u/5243748/mFHW Landscape_2016 Final.pdf
Bagonza J, Rutebemberwa E, Bazeyo W Adherence to anti diabetic medication among patients with diabetes in eastern Uganda; a cross sectional study. BMC Health Serv Res. 2015 Apr 19;15:168. doi: 10.1186/s12913-015-0820-5.
Binagwaho A Role of community health in strengthening Rwandan health system [Internet]. 2011 [cited 2016 Feb 6]. Available from: http://www.webcitation.org/6f5urhqiP
Bloomfield GS, Vedanthan R, Vasudevan L, Kithei A, Were M, Velazquez EJ Mobile health for non-communicable diseases in Sub-Saharan Africa: a systematic review of the literature and strategic framework for research. Global Health. 2014 Jun 13;10:49. doi: 10.1186/1744-8603-10-49. Review.
Boyer JG, Earp JA The development of an instrument for assessing the quality of life of people with diabetes. Diabetes-39. Med Care. 1997 May;35(5):440-53.
Braun R, Catalani C, Wimbush J, Israelski D Community health workers and mobile technology: a systematic review of the literature. PLoS One. 2013 Jun 12;8(6):e65772. doi: 10.1371/journal.pone.0065772. Print 2013. Review.
Cramer JA A systematic review of adherence with medications for diabetes. Diabetes Care. 2004 May;27(5):1218-24. Review.
Dodson S, Good S, Osborne R Health literacy toolkit for low- and middle-income countries: a series of information sheets to empower communities and strengthen health systems [Internet]. National Network of Libraries of Medicine Southeastern/Atlantic Region. New Delhi: World Health Organization, Regional Office for South-East Asia; 2015. Available from: http://apps.searo.who.int/PDS_DOCS/B5148.pdf?ua=1
Garratt AM, Schmidt L, Fitzpatrick R Patient-assessed health outcome measures for diabetes: a structured review. Diabet Med. 2002 Jan;19(1):1-11. Review.
Gill GV, Mbanya JC, Ramaiya KL, Tesfaye S A sub-Saharan African perspective of diabetes. Diabetologia. 2009 Jan;52(1):8-16. doi: 10.1007/s00125-008-1167-9. Epub 2008 Oct 10. Review.
GSMA The Mobile Economy: Sub Saharan Africa 2014 [Internet]. London, United Kingdom; 2014. Available from: http://www.gsmamobileeconomyafrica.com/GSMA_ME_SubSaharanAfrica_Web_Singles.pdf
Hall V, Thomsen RW, Henriksen O, Lohse N Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health implications. A systematic review. BMC Public Health. 2011 Jul 14;11:564. doi: 10.1186/1471-2458-11-564. Review.
Hamine S, Gerth-Guyette E, Faulx D, Green BB, Ginsburg AS Impact of mHealth chronic disease management on treatment adherence and patient outcomes: a systematic review. J Med Internet Res. 2015 Feb 24;17(2):e52. doi: 10.2196/jmir.3951. Review.
Hilawe EH, Yatsuya H, Kawaguchi L, Aoyama A Differences by sex in the prevalence of diabetes mellitus, impaired fasting glycaemia and impaired glucose tolerance in sub-Saharan Africa: a systematic review and meta-analysis. Bull World Health Organ. 2013 Sep 1;91(9):671-682D. doi: 10.2471/BLT.12.113415. Review.
International Diabetes Federation Global Diabetes Scorecard Tracking Progress for Action [Internet]. Bruxelles; 2014. Available from: http://www.idf.org/global-diabetes-scorecard/assets/downloads/Scorecard-29-07-14.pdf
Joshi R, Alim M, Kengne AP, Jan S, Maulik PK, Peiris D, Patel AA Task shifting for non-communicable disease management in low and middle income countries--a systematic review. PLoS One. 2014 Aug 14;9(8):e103754. doi: 10.1371/journal.pone.0103754. eCollection 2014. Review.
Lam WY, Fresco P Medication Adherence Measures: An Overview. Biomed Res Int. 2015;2015:217047. doi: 10.1155/2015/217047. Epub 2015 Oct 11. Review.
Lavsa SM, Holzworth A, Ansani NT Selection of a validated scale for measuring medication adherence. J Am Pharm Assoc (2003). 2011 Jan-Feb;51(1):90-4. doi: 10.1331/JAPhA.2011.09154. Review.
Levitt NS, Bradshaw D, Zwarenstein MF, Bawa AA, Maphumolo S Audit of public sector primary diabetes care in Cape Town, South Africa: high prevalence of complications, uncontrolled hyperglycaemia, and hypertension. Diabet Med. 1997 Dec;14(12):1073-7.
Mash RJ, Rhode H, Zwarenstein M, Rollnick S, Lombard C, Steyn K, Levitt N Effectiveness of a group diabetes education programme in under-served communities in South Africa: a pragmatic cluster randomized controlled trial. Diabet Med. 2014 Aug;31(8):987-93. doi: 10.1111/dme.12475. Epub 2014 May 20.
Ministry of Health (MOH) [Rwanda] Health Sector Annual Report: July 2015-June 2016 [Internet]. Kigali; 2016. Available from: http://www.moh.gov.rw/fileadmin/templates/MOH-Reports/Health_20Sector_20Annual_20Report_202015-2016_25082016.pdf
Ministry of Health (MOH) [Rwanda] Health Sector Policy [Internet]. Kigali; 2014. Available from: http://www.moh.gov.rw/fileadmin/templates/policies/Health_Sector_Policy_2014.pdf
Ministry of Health (MOH) [Rwanda] Non communicable diseases policy [Internet]. 2015. Available from: http://www.moh.gov.rw/fileadmin/templates/policies/NCDs_Policy.2015.pdf
Mishra SR, Neupane D, Preen D, Kallestrup P, Perry HB Mitigation of non-communicable diseases in developing countries with community health workers. Global Health. 2015 Nov 10;11:43. doi: 10.1186/s12992-015-0129-5.
Mrc, Clark A, Clark A Anonymising Research Data. Sociol J Br Sociol Assoc. 2006;44:1-48
Mukeshimana MM, Nkosi ZZ Communities' knowledge and perceptions of type two diabetes mellitus in Rwanda: a questionnaire survey. J Clin Nurs. 2014 Feb;23(3-4):541-9. doi: 10.1111/jocn.12199. Epub 2013 Jun 21.
Speight J, Reaney MD, Barnard KD Not all roads lead to Rome-a review of quality of life measurement in adults with diabetes. Diabet Med. 2009 Apr;26(4):315-27. doi: 10.1111/j.1464-5491.2009.02682.x. Review.
Stephani V, Opoku D, Quentin W A systematic review of randomized controlled trials of mHealth interventions against non-communicable diseases in developing countries. BMC Public Health. 2016 Jul 15;16:572. doi: 10.1186/s12889-016-3226-3. Review.
Svarstad BL, Chewning BA, Sleath BL, Claesson C The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999 Jun;37(2):113-24.
Tapela N, Habineza H, Anoke S, Harerimana E, Mutabazi F, Hedt-Gauthier B, et al Diabetes in Rural Rwanda: High Retention and Positive Outcomes after 24 Months of Follow-up in the Setting of Chronic Care Integration. Int J Diabetes Clin Res [Internet]. 2016 [cited 2016 Dec 5];3(2). Available from: http://clinmedjournals.org/articles/ijdcr/international-journal-of-diabetes-and-clinical-research-ijdcr-3-058.php
Torgerson DJ Contamination in trials: is cluster randomisation the answer? BMJ. 2001 Feb 10;322(7282):355-7. Review.
Torjesen I Maternal deaths have nearly halved in past 25 years. BMJ. 2015 Nov 13;351:h6129. doi: 10.1136/bmj.h6129.
Utilities Rwanda Regulatory Authority Statistics and tariff information in telecommunication, media and postal service as of the fourth quarter 2016 [Internet]. 2016. Available from: http://www.rura.rw/fileadmin/docs/statistics/Statistics_report_4th_quarter___2016_for_publication_.pdf
van Teijlingen E, Hundley V The importance of pilot studies. Nurs Stand. 2002 Jun 19-25;16(40):33-6. Review.
Vital Wave Consulting mHealth for Development: The Opportunity of Mobile Technology for Healthcare in the Developing World [Internet]. Washington, D.C.; 2009. Available from: http://www.unfoundation.org/what-we-do/issues/global-health/mhealth-report.html
Watkins K, Connell CM Measurement of health-related QOL in diabetes mellitus. Pharmacoeconomics. 2004;22(17):1109-26. Review.
World Health Organization (WHO) Adherence to long-term therapies: evidence for action. 2003;2014:1-194. Available from: http://www.who.int/chp/knowledge/publications/adherence_full_report.pdf
World Health Organization (WHO) Global status report on noncommunicable diseases 2014. 2014;298. Available from: http://www.who.int/nmh/publications/ncd-status-report-2014/en/
World Health Organization (WHO) ITU and WHO launch mHealth initiative to combat noncommunicable diseases [Internet]. 2012 [cited 2016 Feb 6]. Available from: http://www.who.int/nmh/events/2012/mhealth/en/
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
